MapLight Therapeutics, Inc. Common Stock (MPLT)

MapLight Therapeutics, Inc. Common Stock (MPLT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $458M; returns 1 day -3.4%, 1 week +3.5%.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system (CNS) disorders.

Groups MPLT belongs to

• Biotechnology
• Clinical Stage Biotech
• Recent IPOs
• CNS Disorders
• Neuroscience
• Biopharmaceutical
• Neurological Disorders
• Healthcare
• Clinical Stage
• Alzheimer's Disease
• Mental Health Solutions

MPLT financial model: income statement, cash flow and balance sheet